This practical book focuses on the most recent advances in fertility preservation in oncological and non-oncological patients. It presents the steps that need to be followed prior to treatment for successful fertility preservation, and describes in detail the medical conditions requiring fertility preservation, including precise information on the risk of fertility loss, prognosis, risk of ovarian metastasis and other possible risks. The book also provides information on how to perform the preservation techniques (success rates, risks, etc.) and on what to do after the treatment (in…mehr
This practical book focuses on the most recent advances in fertility preservation in oncological and non-oncological patients.
It presents the steps that need to be followed prior to treatment for successful fertility preservation, and describes in detail the medical conditions requiring fertility preservation, including precise information on the risk of fertility loss, prognosis, risk of ovarian metastasis and other possible risks.
The book also provides information on how to perform the preservation techniques (success rates, risks, etc.) and on what to do after the treatment (in cases of bleeding during chemotherapy, menopause, wish to conceive, etc.). Written by experts in the field, including members of the globally known network FertiPROTEKT and leading oncologists and specialists, this practical and easy-to-use book is a valuable resource for all clinicians involved in fertility preservation for patients with specific diseases
Michael von Wolff is Head of the Division of Gynaecological Endocrinology and Reproductive Medicine at the Women`s University Hospital, Berne, Switzerland. He has studied and worked in Germany, London, New York and most recently in Switzerland. His research focuses on fertility preservation and natural cycle IVF, as well as ovarian stimulation and ovarian tissue transplantation and has published several books and papers. He established the German-language network of fertility preservation before cytotoxic therapies "FertiPROTEKT" (www.fertiprotekt.com) in 2006. He also founded the ESHRE Task Force on Fertility Preservation, has co-founded the Special Interest Group "Fertility preservation" of European Society of Human Reproduction and Embryology, ESHRE and is Vice president of the International Society for Fertility Preservation, ISFP. Frank Nawroth Prof. Dr. med., was a Senior Physician and Head of the Department of Gynecological Endocrinology and Reproductive Medicine at the University Women's Hospital in Cologne from 1999-2004, and since 2008 has been an Adjunct Professor of Gynecology and Obstetrics there. Since 2010 he has been working at the Center for Infertility, Prenatal Medicine, Endocrinology and Osteology at Barkhof, Hamburg, where he focuses mainly on fertility preservation and treatment of infertility. He has published several books and papers and is a member of the FertiPROTEKT board.
Inhaltsangabe
ForewordPrefaceList of ContributorsDedication Part IBefore fertility preservation 1How to use the book 2Networks for fertility preservation 3FertiPROTEKT network 4Logistics for fertility preservation counselling 5Indication for and against fertility preservation Part IIFertility preservation - diseases 6Breast cancer 7Hodgkin's lymphoma 8Acute Leukemia 9Ovarian tumors and ovarian cancer 10Cervical cancer 11Endometrial hyperplasia and endometrial carcinoma 12Pediatric oncological cancer 13Other malignancies 14 Non-malignant diseases requiring stem cell transplantation 15Severe autoimmune diseases 16Endometriosis 17Turner syndrome 18Transgender Part III Fertility preservation - techniques 19Ovarian stimulation to collect oocytes 20Cryopreservation of unfertilized and fertilized oocytes 21Removal of ovarian tissue 22Transportation, cryopreservation and storage of ovarian tissue 23Transplantation of ovarian tissue 24GnRH agonists 25Transposition of ovaries 26Cryopreservation of sperm and testicular tissue 27Further fertility preservation techniques Part IVAfter fertility preservation 28Therapy of uterine bleeding during chemotherapy 29Infertility treatment after fertility preservation therapies 30Pregnancy after chemotherapy and radiation of the pelvis 31Premature ovarian insufficiency - Hormone replacement therapy and follow up Part VFurther information Abbreviations
ForewordPrefaceList of ContributorsDedication Part IBefore fertility preservation 1How to use the book 2Networks for fertility preservation 3FertiPROTEKT network 4Logistics for fertility preservation counselling 5Indication for and against fertility preservation Part IIFertility preservation - diseases 6Breast cancer 7Hodgkin's lymphoma 8Acute Leukemia 9Ovarian tumors and ovarian cancer 10Cervical cancer 11Endometrial hyperplasia and endometrial carcinoma 12Pediatric oncological cancer 13Other malignancies 14 Non-malignant diseases requiring stem cell transplantation 15Severe autoimmune diseases 16Endometriosis 17Turner syndrome 18Transgender Part III Fertility preservation - techniques 19Ovarian stimulation to collect oocytes 20Cryopreservation of unfertilized and fertilized oocytes 21Removal of ovarian tissue 22Transportation, cryopreservation and storage of ovarian tissue 23Transplantation of ovarian tissue 24GnRH agonists 25Transposition of ovaries 26Cryopreservation of sperm and testicular tissue 27Further fertility preservation techniques Part IVAfter fertility preservation 28Therapy of uterine bleeding during chemotherapy 29Infertility treatment after fertility preservation therapies 30Pregnancy after chemotherapy and radiation of the pelvis 31Premature ovarian insufficiency - Hormone replacement therapy and follow up Part VFurther information Abbreviations
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309